Lataa...
MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets
Melanoma is the utmost fatal kind of skin neoplasms. Molecular changes occurring during the pathogenic processes of initiation and progression of melanoma are diverse and include activating mutations in BRAF and NRAS genes, hyper-activation of PI3K/AKT pathway, inactivation of p53 and alterations in...
Tallennettuna:
| Julkaisussa: | Front Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8100681/ https://ncbi.nlm.nih.gov/pubmed/33968718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.608987 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|